The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.

Judge Vivian Medinilla of Delaware Superior Court issued an order, which found that plaintiffs’ claims that Zantac (ranitidine) could cause multiple types of cancer were “reliable and ...

Among the thousands that participated in the Authentic Marathon of Athens was 88-year-old Greek runner Ploutarchos Pourliakas who finished in 6 hours and 31 minutes. "I achieved to finish and even ...

Zantac Litigation is Born “The best starting point involves a private company known as Valisure. Valisure theorized that ranitidine [aka Zantac] has the potential to degrade into a carcinogen known as ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

Internal political squabbles — and the fallout from a global backlash to inflation, immigration and ruling elites — are hobbling Germany and France. By Jim Tankersley and Aurelien Breeden ...

Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

Benjamin Netanyahu spoke with Donald Trump to strengthen the alliance between Israel and the United States.

The president-elect’s call for Taiwan to spend more on its own defense and his complaints about its semiconductor dominance may herald a tenser relationship. By Chris Buckley and Amy Chang ...